PSIX
Power Solutions International, Inc.
PSIX has a slight edge over RKLB overall, supported by lower modeled downside and stronger modeled upside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
PSIX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Strong | |
| Strong |
PSIX's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
PSIX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.1x | $9.56 | -76% |
| Fair | 10x | $31.91 | -19% |
| Forward | 11x | $39.42 | — |
| Current | 13x | $39.42 | — |
| Expensive | 17x | $52.04 | +32% |
Historical ranges are pointers, not guarantees.
PSIX's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
PSIX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PSIX, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PSIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.55 | +17% |
| Q3 2026 | $3.04 | -42% |
| Q2 2026 | $2.94 | -39% |
| Q1 2026 | $4.43 | +25% |
| Q4 2025 | $4.94 | +64% |
| Q3 2025 | $5.26 | +122% |
| Q2 2025 | $4.81 | +145% |
| Q1 2025 | $3.53 | +172% |
| Q4 2024 | $3.01 | +162% |
PSIX has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
PSIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $202.1M | -0.9% |
| Q2 2026 | $152.5M | -21% |
| Q1 2026 | $128.6M | -5.1% |
| Q4 2025 | $191.2M | +33% |
| Q3 2025 | $203.8M | +62% |
| Q2 2025 | $191.9M | +74% |
| Q1 2025 | $135.4M | +42% |
| Q4 2024 | $144.3M | +38% |
PSIX's revenue has held roughly level: $202M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +6.3 points |
| Q2 2026 | 16% | -1.3 points |
| Q1 2026 | 8.9% | -9.3 points |
| Q4 2025 | 13% | -4.8 points |
| Q3 2025 | 14% | -2.3 points |
| Q2 2025 | 17% | -6 points |
| Q1 2025 | 18% | +7 points |
| Q4 2024 | 17% | +5.7 points |
PSIX has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over PSIX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
PSIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $38.3M | +2119% |
| Q2 2026 | $55.7M | +281% |
| Q1 2026 | $17.2M | +219% |
| Q4 2025 | -$7.6M | -125% |
| Q3 2025 | $1.7M | -86% |
| Q2 2025 | $14.6M | +1679% |
| Q1 2025 | $5.4M | -63% |
| Q4 2024 | $30M | +398% |
PSIX has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
PSIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +3K shares |
| 1 year | +0.1% | +14K shares |
| 3 years | +0.4% | +101K shares |
| 5 years | +0.7% | +155K shares |
| Available history | +7.2% | +1.5M shares |
PSIX has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PSIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.8x | Very low |
PSIX has more cash than debt.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PSIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 49.7 | Neutral |
PSIX's weekly RSI is 44 (neutral) and its Stochastic is 50 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
PSIX PE vs Industrials Sector
| Metric | PSIX | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 24x | 46% below |
| PE % | 66 | 58 | 8 pts above |
PSIX is trading at 13x earnings, a 46% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
PSIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.7 | 12% below |
| 20 week MA | $40.0 | 1.4% below |
| 50 week MA | $54.1 | 27% below |
| 100 week MA | $55.3 | 29% below |
| 200 week MA | $31.2 | 27% above |
PSIX has fallen below most of its moving averages, though it's still 27% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over PSIX on trend strength, trading above more of its moving averages.
PSIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.25 | $3.26 | -23% |
| 2021 | $3.26 | $2.95 | -9.5% |
| 2022 | $2.95 | $2.92 | -1% |
| 2023 | $2.92 | $2.05 | -30% |
| 2024 | $2.05 | $27.1 | +1220% |
| 2025 | $27.1 | $65.5 | +142% |
| 2026 YTD | $65.5 | $39.4 | -40% |
PSIX has finished lower in four of the last six years. It's down 40% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over PSIX on returns for 2026, with the stronger performance.